Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

The purpose of the study was to establish the optimal dose of capecitabine (X) to be used within a multicentre, randomised study evaluating the potential roles of oxaliplatin (O) and X in chemonaive patients (pts) with advanced oesophagogastric cancer. Two by two design was used, and pts were random...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sumpter, K, Harper-Wynne, C, Cunningham, D, Rao, S, Tebbutt, N, Norman, A R, Ward, C, Iveson, T, Nicolson, M, Hickish, T, Hill, M, Oates, J
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2005
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361798/
https://ncbi.nlm.nih.gov/pubmed/15928658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602572
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars